Vitality Watch

⚠ Evidence note: Most trends in this area rest on anecdote and mechanism; where real evidence exists it is usually for narrower claims than the trend makes.

Mentioned 1× · first seen 07-oct-2026 · last seen 07-oct-2026

FDA Aging Regulatory Science Agenda

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-10-02 — FDA Leaders Name Longevity a Priority at ARDD: 2026 — ARDD Boston press coverage: FDA senior officials publicly named longevity a priority and said aging will be added to the agency’s regulatory science agenda, with discussion of how longevity therapies could be regulated; conference statements only, no draft guidance or rulemaking released. [expert-opinion] (novelty: 4)

Open questions

Related

Contributing findings

rss news report expert-opinion
FDA Leaders Name Longevity a Priority at ARDD
02-oct-2026 novelty 4 per-area 4 strengthens

build build 880 · 2bcef25 · 2026-11-18